Rockwell Medical Inc
General ticker "RMTI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $68.0M
Rockwell Medical Inc follows the US Stock Market performance with the rate: 42.3%.
Estimated limits based on current volatility of 4.0%: low 2.04$, high 2.21$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.65$, 3.91$]
- 2024-12-30 to 2025-12-30 estimated range: [1.57$, 3.77$]
Financial Metrics affecting the RMTI estimates:
- Negative: Non-GAAP EPS, $ of -0.33 <= 0.10
- Negative: Operating profit margin, % of -7.39 <= 1.03
- Negative: Operating cash flow per share per price, % of -18.48 <= 2.35
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.13
- Positive: Interest expense per share, $ of 0.10 <= 0.14
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
Short-term RMTI quotes
Long-term RMTI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $61.93MM | $72.81MM | $83.61MM |
| Operating Expenses | $92.27MM | $89.59MM | $90.28MM |
| Operating Income | $-30.34MM | $-16.78MM | $-6.67MM |
| Non-Operating Income | $-2.34MM | $-1.90MM | $-1.77MM |
| Interest Expense | $2.36MM | $1.94MM | $2.30MM |
| R&D Expense | $6.83MM | $3.12MM | $1.11MM |
| Income(Loss) | $-32.67MM | $-18.68MM | $-8.44MM |
| Taxes | $2.36MM | $1.90MM | $0.00MM |
| Profit(Loss) | $-35.03MM | $-20.58MM | $-8.44MM |
| Stockholders Equity | $2.54MM | $14.11MM | $21.29MM |
| Inventory | $4.08MM | $5.81MM | $5.87MM |
| Assets | $48.57MM | $46.63MM | $52.17MM |
| Operating Cash Flow | $-33.53MM | $-17.41MM | $-9.41MM |
| Capital expenditure | $0.52MM | $0.28MM | $0.28MM |
| Investing Cash Flow | $0.31MM | $-2.40MM | $-3.04MM |
| Financing Cash Flow | $-2.18MM | $16.63MM | $11.34MM |
| Earnings Per Share* | $-4.11 | $-2.09 | $-0.36 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.